Compositions and methods for the prevention and treatment of Huntington's disease

Details for Australian Patent Application No. 2002326589 (hide)

Owner University of Delaware

Inventors Parekh-olmedo, Hetal; Kmiec, Eric B

Agent Cullen & Co

Pub. Number AU-B-2002326589

PCT Number PCT/US02/25352

PCT Pub. Number WO2003/013437

Priority 60/310,770 08.08.01 US; 60/310,757 07.08.01 US; 60/310,889 08.08.01 US; 60/337,219 04.12.01 US

Filing date 7 August 2002

Wipo publication date 24 February 2003

Acceptance publication date 5 June 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 60/310,770 08.08.01 US; 60/310,757 07.08.01 US; 60/310,889 08.08.01 US; 60/337,219 04.12.01 US

19 June 2003 Application Open to Public Inspection

  Published as AU-B-2002326589

5 June 2008 Application Accepted

  Published as AU-B-2002326589

2 October 2008 Standard Patent Sealed

4 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002326590-Selective estrogen receptor modulators

2002326588-A METHOD AND SYSTEM FOR DYNAMIC RISK ASSESSMENT, RISK MONITORING, AND CASELOAD MANAGEMENT